Export

Meglumine antimoniate
Essential medicine status
General description
Meglumine antimoniate is a antimony derivative used to treat visceral, cutaneous and mucosal leishmaniasis.
Medicine type
Chemical agent
EML status history
First added in 1987 (TRS 770) for Visceral leishmaniasis
Recommendations
Section
Antileishmaniasis medicines
  • Parenteral > General injections > IM: 30% in 5 mL ampoule equivalent to approximately 8.1% antimony